CIK 0001070081
- Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043416587
- Phone
- +1 908-222-7000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,548,017
- in 9 filings, $7.5M under 10b5-1 plans
Net −$7,548,017. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-03 | Boulding Mark Elliott EXEC. VP AND CLO | Grant or award | +18,000 | 110,389 | ||
| 2025-01-03 | Boulding Mark Elliott EXEC. VP AND CLO | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2025-01-03 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Grant or award | +19,000 | 106,048 | ||
| 2025-01-03 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Grant or award | +715 | 6,137 | ||
| 2025-01-03 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Grant or award · Stock Option (Right to Buy) | +47,500 | 47,500 | ||
| 2025-01-03 | Golden Lee Scott EVP & CHIEF MEDICAL OFFICER | Grant or award | +20,000 | 80,659 | ||
| 2025-01-03 | Golden Lee Scott EVP & CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-01-03 | Pauwels Eric CHIEF EXECUTIVE OFFICER | Grant or award | +22,000 | 90,540 | ||
| 2025-01-03 | Pauwels Eric CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2025-01-03 | Gravier Pierre CHIEF FINANCIAL OFFICER | Grant or award | +22,500 | 76,771 | ||
| 2025-01-03 | Gravier Pierre CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +56,250 | 56,250 | ||
| 2025-01-03 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Grant or award | +70,000 | 288,374 | ||
| 2025-01-03 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2024-12-31 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −8,279 | $45.16 | $374K | 217,528 |
| 2024-12-03 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise 10b5-1 | +600 | $33.02 | $20K | 92,989 |
| 2024-12-03 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −600 | $53.04 | $32K | 92,389 |
| 2024-12-03 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise 10b5-1 | +7,720 | $33.02 | $255K | 100,109 |
| 2024-12-03 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −6,315 | $53.14 | $336K | 93,794 |
| 2024-12-03 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −1,405 | $54.05 | $76K | 92,389 |
| 2024-12-03 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise 10b5-1 | +1,988 | $33.02 | $66K | 94,377 |
Page 30 of 41 · 804 trades